Third, we further investigated the possible regulation of BIRC6 by NFYC-AS1 and related influences on lung cancer cells, proving that NFYC-AS1 may act not only as an indicator for poor prognosis but also as a potential driver of carcinogenesis through the negative modulation of autophagy and apoptosis. Here, BIRC6 is linked to lung carcinoma.